Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2005 1
2006 2
2007 2
2009 2
2010 1
2011 1
2012 1
2013 2
2014 1
2015 3
2016 3
2017 1
2018 2
2019 2
2020 2
2021 6
2022 2
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors.
Tsuji K, Kobayakawa T, Konno K, Masuda A, Takahashi K, Ohashi N, Yoshimura K, Kuwata T, Matsushita S, Harada S, Tamamura H. Tsuji K, et al. Among authors: kuwata t. Bioorg Med Chem. 2022 Feb 15;56:116616. doi: 10.1016/j.bmc.2022.116616. Epub 2022 Jan 12. Bioorg Med Chem. 2022. PMID: 35063895
Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates.
Matsumoto K, Kuwata T, Tolbert WD, Richard J, Ding S, Prévost J, Takahama S, Judicate GP, Ueno T, Nakata H, Kobayakawa T, Tsuji K, Tamamura H, Smith AB 3rd, Pazgier M, Finzi A, Matsushita S. Matsumoto K, et al. Among authors: kuwata t. J Virol. 2023 Jan 31;97(1):e0163822. doi: 10.1128/jvi.01638-22. Epub 2022 Dec 13. J Virol. 2023. PMID: 36511698 Free PMC article.
Hybrids of Small-Molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry Inhibitors.
Kobayakawa T, Tsuji K, Konno K, Himeno A, Masuda A, Yang T, Takahashi K, Ishida Y, Ohashi N, Kuwata T, Matsumoto K, Yoshimura K, Sakawaki H, Miura T, Harada S, Matsushita S, Tamamura H. Kobayakawa T, et al. Among authors: kuwata t. J Med Chem. 2021 Feb 11;64(3):1481-1496. doi: 10.1021/acs.jmedchem.0c01153. Epub 2021 Jan 26. J Med Chem. 2021. PMID: 33497209
Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.
Kaku Y, Kuwata T, Zahid HM, Hashiguchi T, Noda T, Kuramoto N, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, Shimura K, Onishi C, Muramoto Y, Suzuki T, Sasaki J, Nagasaki Y, Minami R, Motozono C, Toyoda M, Takahashi H, Kishi H, Fujii K, Tatsuke T, Ikeda T, Maeda Y, Ueno T, Koyanagi Y, Iwagoe H, Matsushita S. Kaku Y, et al. Among authors: kuwata t. Cell Rep. 2021 Jul 13;36(2):109385. doi: 10.1016/j.celrep.2021.109385. Epub 2021 Jun 25. Cell Rep. 2021. PMID: 34237284 Free PMC article.
Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay.
Toyoda M, Tan TS, Motozono C, Barabona G, Yonekawa A, Shimono N, Minami R, Nagasaki Y, Miyashita Y, Oshiumi H, Nakamura K, Matsushita S, Kuwata T, Ueno T. Toyoda M, et al. Among authors: kuwata t. Microbiol Spectr. 2023 Aug 17;11(4):e0066023. doi: 10.1128/spectrum.00660-23. Epub 2023 Jun 13. Microbiol Spectr. 2023. PMID: 37310218 Free PMC article.
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y, Takemura T, Chikata T, Kuwata T, Terasawa H, Fujimoto R, Kuse N, Akahoshi T, Murakoshi H, Tran GV, Zhang Y, Pham CH, Pham AHQ, Monde K, Sawa T, Matsushita S, Nguyen TV, Nguyen KV, Hasebe F, Yamashiro T, Takiguchi M. Maeda Y, et al. Among authors: kuwata t. J Virol. 2020 Jun 1;94(12):e00193-20. doi: 10.1128/JVI.00193-20. Print 2020 Jun 1. J Virol. 2020. PMID: 32295903 Free PMC article.
41 results